Janney Montgomery Scott LLC

Position in CADL — Candel Therapeutics, Inc.

CIK 1329948 PHILADELPHIA, PA

Position in CADL

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$324,161

+$174,849 QoQ

Shares Held

31,472

+3.3% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#74

of 138 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Janney Montgomery Scott LLC holds $121,989,266 across 55 Biotechnology names. CADL ranks #42 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	85,735	$42,587,146
2	SPRY	ARS Pharmaceuticals, Inc.	2,064,498	$16,536,628
3	REGN	Regeneron Pharmaceuticals, Inc.	12,176	$7,592,223
4	INCY	Incyte Corp	52,727	$5,977,132
5	EXEL	Exelixis, Inc.	89,664	$4,878,618
6	ZVRA	Zevra Therapeutics, Inc.	272,194	$3,903,261
7	AXSM	Axsome Therapeutics, Inc.	13,087	$3,203,304
8	ROIV	Roivant Sciences Ltd.	79,550	$2,815,274

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$324,161	31,472	+3.3%	Shares	Sole	2026-08-05
2026-03-31	$149,312	30,472	+12.6%	Shares	Sole	2026-04-22
2025-12-31	$152,956	27,072	-10.9%	Shares	Sole	2026-02-11
2025-09-30	$154,968	30,386	+11.3%	Shares	Sole	2025-10-27
2025-06-30	$138,087	27,290	+29.4%	Shares	Sole	2025-07-17
2025-03-31	$119,158	21,090	+104.3%	Shares	Sole	2025-04-17
2024-12-31	$89,621	10,325	-11.5%	Shares	Sole	2025-01-17
2024-09-30	$80,838	11,665	+0.4%	Shares	Sole	2024-10-29
2024-06-30	$72,013	11,615	—	Shares	Sole	2024-07-25
No filing history on record for this holder in this stock.